Kashiv BioSciences Secures INR 684 Crore to Build Biopharma Facility
Kashiv BioSciences has secured INR 648 crore in financing from Union Bank of India to invest in a state-of-the-art biologics manufacturing facility in Pipan, Gujarat, aimed at strengthening technical capabilities, enhancing global competitiveness, and generating long-term, high-value employment across scientific, technical and operational roles.
Biopharmaceutical Manufacturing | 26/12/2025 | By News Bureau
Biopharmaceutical Manufacturing | 14/05/2024 | By Abha | 668
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy